Mohammed A Quader

Summary

Affiliation: Virginia Commonwealth University
Country: USA

Publications

  1. doi request reprint Heart transplantation outcomes in patients with continuous-flow left ventricular assist device-related complications
    Mohammed A Quader
    Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, Virginia Electronic address
    J Heart Lung Transplant 34:75-81. 2015
  2. doi request reprint Heart transplantation outcomes from cardiac arrest-resuscitated donors
    Mohammed A Quader
    Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, Virginia Electronic address
    J Heart Lung Transplant 32:1090-5. 2013
  3. doi request reprint Left ventricular assist device and heart transplantation in hemophilia a patient
    Mohammed Quader
    Department of Surgery, McGuire Veterans Medical Center, Richmond, Virginia Electronic address
    Ann Thorac Surg 96:2245-7. 2013
  4. doi request reprint Dobutamine induced eosinophilic myocarditis and right heart failure requiring emergent biventricular assist device implantation
    Vikram P Raje
    From the Department of Internal Medicine, Division of Cardiovascular Disease, Virginia Commonwealth University, Richmond, Virginia and Hunter Holmes McGuire Veterans Medical Center, Richmond, Virginia
    ASAIO J 61:213-5. 2015
  5. doi request reprint Safety analysis of intermittent hemodialysis in patients with continuous flow left ventricular assist devices
    Mohammed A Quader
    Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, VA, USA
    Hemodial Int 18:205-9. 2014

Collaborators

Detail Information

Publications5

  1. doi request reprint Heart transplantation outcomes in patients with continuous-flow left ventricular assist device-related complications
    Mohammed A Quader
    Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, Virginia Electronic address
    J Heart Lung Transplant 34:75-81. 2015
    ..We studied the heart transplant (HTx) outcomes of United Network of Organ Sharing (UNOS) Status 1A patients supported with CF-LVADs with (+) or without (-) DRCs...
  2. doi request reprint Heart transplantation outcomes from cardiac arrest-resuscitated donors
    Mohammed A Quader
    Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, Virginia Electronic address
    J Heart Lung Transplant 32:1090-5. 2013
    ..The aim of this study was to compare the outcomes of heart transplantation from cardiopulmonary-resuscitated donors (CPR(+)) to those who received hearts from donors who did not require cardiopulmonary resuscitation (CPR(-))...
  3. doi request reprint Left ventricular assist device and heart transplantation in hemophilia a patient
    Mohammed Quader
    Department of Surgery, McGuire Veterans Medical Center, Richmond, Virginia Electronic address
    Ann Thorac Surg 96:2245-7. 2013
    ..Preparation for surgery with factor VIII supplementation, intraoperative conduct of surgery, and challenges of postoperative course are described with a brief literature review. ..
  4. doi request reprint Dobutamine induced eosinophilic myocarditis and right heart failure requiring emergent biventricular assist device implantation
    Vikram P Raje
    From the Department of Internal Medicine, Division of Cardiovascular Disease, Virginia Commonwealth University, Richmond, Virginia and Hunter Holmes McGuire Veterans Medical Center, Richmond, Virginia
    ASAIO J 61:213-5. 2015
    ..He had a predominance of right heart failure, requiring an urgent biventricular assist device and acutely responded to withdrawal of dobutamine. ..
  5. doi request reprint Safety analysis of intermittent hemodialysis in patients with continuous flow left ventricular assist devices
    Mohammed A Quader
    Division of Cardiothoracic Surgery, Virginia Commonwealth University, Richmond, VA, USA
    Hemodial Int 18:205-9. 2014
    ..7%), and abdominal cramps--1 (0.36%). Volume expansion was necessary on three occasions. Low-flow device alarms were registered during two (0.71%) sessions. The results showed no serious adverse effects or deaths...